Who invested in Pathway Therapeutics?
Pathway Therapeutics's investors include GBS Ventures, CM Capital Investments and New Zealand Growth Capital Partners.
United States · Funded startup
5 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$24Mraised across 5 rounds since 2008, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $400K sold, first sale Feb 2013
Reported by pathwaytx.comSEC filing: $7.5M sold, first sale May 2011
Reported by pathwaytx.comSEC filing: $8.8M sold, first sale Jul 2010
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Pathway Therapeutics's investors include GBS Ventures, CM Capital Investments and New Zealand Growth Capital Partners.
Pathway Therapeutics has raised $24M across 5 rounds since 2008.
Pathway Therapeutics's most recent round was a Debt of $400K in Mar 2013.
Pathway Therapeutics's largest round on record is $9.6M (Series A), in Jun 2008.
Pathway Therapeutics's first round on record, in Jun 2008, was backed by GBS Ventures and CM Capital Investments.
Pathway Therapeutics's latest named round is a Debt, in Mar 2013.
Pathway Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.